Works in Neuro-Oncology, 2019, Vol 21, Issue 12

Results: 20

Forthcoming Meetings.

Published in:: Neuro-Oncology, 2019, v. 21, n. 12, p. 1614, doi. 10.1093/neuonc/noz210
Publication type:: Article

Highlights from the Literature.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1495, doi. 10.1093/neuonc/noz211

By:

Purow, Benjamin;
Charest, Alain;
Gerstner, Elizabeth;
Hegi, Monika;
Aldape, Kenneth

Publication type:

Article

A new chance for EGFR inhibition in glioblastoma?

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1487, doi. 10.1093/neuonc/noz196

By:

Johannessen, Tor-Christian Aase;
Bjerkvig, Rolf

Publication type:

Article

Tackling 1q+ PFA ependymomas.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1489, doi. 10.1093/neuonc/noz194

By:

Agnihotri, Sameer

Publication type:

Article

Imaging biomarkers for brain metastases: more than meets the eye.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1493, doi. 10.1093/neuonc/noz193

By:

Aneja, Sanjay;
Omuro, Antonio

Publication type:

Article

"Not all that glitters is gold": insights from the Far East and how to solve a conundrum.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1490, doi. 10.1093/neuonc/noz188

By:

Gottardo, Nicholas G;
Bartels, Ute

Publication type:

Article

The anticipated revision of the grading criteria for adult isocitrate dehydrogenase–mutant diffuse glioma within the neuro-oncology community.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1485, doi. 10.1093/neuonc/noz186

By:

Komori, Takashi

Publication type:

Article

Comment on "Hypometabolic gliomas on FET-PET—is there an inverted U-curve for survival?".

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1612, doi. 10.1093/neuonc/noz173

By:

Galldiks, Norbert;
Verger, Antoine;
Zaragori, Timothée;
Unterrainer, Marcus;
Suchorska, Bogdana;
Lohmann, Philipp;
Tonn, Jörg C;
Langen, Karl-Josef;
Albert, Nathalie L

Publication type:

Article

Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine positron emission tomography (<sup>18</sup>F-FET PET).

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1595, doi. 10.1093/neuonc/noz166

By:

Bashir, Asma;
Jacobsen, Sofie Mathilde;
Henriksen, Otto Mølby;
Broholm, Helle;
Urup, Thomas;
Grunnet, Kirsten;
Larsen, Vibeke Andrée;
Møller, Søren;
Skjøth-Rasmussen, Jane;
Poulsen, Hans Skovgaard;
Law, Ian

Publication type:

Article

Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1610, doi. 10.1093/neuonc/noz157

By:

Pasqualetti, Francesco;
Restante, Giuliana;
Gonnelli, Alessandra;
Rofi, Eleonora;
Molinari, Alessandro;
Crucitta, Stefania;
Paiar, Fabiola;
Rudà, Roberta;
Danesi, Romano;
Soffietti, Riccardo;
Re, Marzia Del

Publication type:

Article

The potential of cerebrospinal fluid–based liquid biopsy approaches in CNS tumors.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1509, doi. 10.1093/neuonc/noz156

By:

Mattox, Austin K;
Yan, Hai;
Bettegowda, Chetan

Publication type:

Article

Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1607, doi. 10.1093/neuonc/noz145

By:

Wirsching, Hans-Georg;
Arora, Sonali;
Zhang, Huajia;
Szulzewsky, Frank;
Cimino, Patrick J;
Quéva, Christophe;
Houghton, A McGarry;
Glorioso, Joseph C;
Weller, Michael;
Holland, Eric C

Publication type:

Article

MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1578, doi. 10.1093/neuonc/noz141

By:

Bhatia, Ankush;
Birger, Maxwell;
Veeraraghavan, Harini;
Um, Hyemin;
Tixier, Florent;
McKenney, Anna Sophia;
Cugliari, Marina;
Caviasco, Annalise;
Bialczak, Angelica;
Malani, Rachna;
Flynn, Jessica;
Zhang, Zhigang;
Yang, T Jonathan;
Santomasso, Bianca D;
Shoushtari, Alexander N;
Young, Robert J

Publication type:

Article

Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1565, doi. 10.1093/neuonc/noz139

By:

Takami, Hirokazu;
Fukuoka, Kohei;
Fukushima, Shintaro;
Nakamura, Taishi;
Mukasa, Akitake;
Saito, Nobuhito;
Yanagisawa, Takaaki;
Nakamura, Hideo;
Sugiyama, Kazuhiko;
Kanamori, Masayuki;
Tominaga, Teiji;
Maehara, Taketoshi;
Nakada, Mitsutoshi;
Kanemura, Yonehiro;
Asai, Akio;
Takeshima, Hideo;
Hirose, Yuichi;
Iuchi, Toshihiko;
Nagane, Motoo;
Yoshimoto, Koji

Publication type:

Article

Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1552, doi. 10.1093/neuonc/noz138

By:

Satterlee, Andrew B;
Dunn, Denise E;
Lo, Donald C;
Khagi, Simon;
Hingtgen, Shawn

Publication type:

Article

Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1587, doi. 10.1093/neuonc/noz131

By:

Furtner, Julia;
Genbrugge, Els;
Gorlia, Thierry;
Bendszus, Martin;
Nowosielski, Martha;
Golfinopoulos, Vassilis;
Weller, Michael;
Bent, Martin J van den;
Wick, Wolfgang;
Preusser, Matthias

Publication type:

Article

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1519, doi. 10.1093/neuonc/noz124

By:

Appay, Romain;
Dehais, Caroline;
Maurage, Claude-Alain;
Alentorn, Agusti;
Carpentier, Catherine;
Colin, Carole;
Ducray, François;
Escande, Fabienne;
Idbaih, Ahmed;
Kamoun, Aurélie;
Marie, Yannick;
Mokhtari, Karima;
Tabouret, Emeline;
Trabelsi, Nesrine;
Uro-Coste, Emmanuelle;
Delattre, Jean-Yves;
Figarella-Branger, Dominique;
Network, POLA

Publication type:

Article

The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1498, doi. 10.1093/neuonc/noz119

By:

Horbinski, Craig;
Ligon, Keith L;
Brastianos, Priscilla;
Huse, Jason T;
Venere, Monica;
Chang, Susan;
Buckner, Jan;
Cloughesy, Timothy;
Jenkins, Robert B;
Giannini, Caterina;
Stupp, Roger;
Nabors, L Burt;
Wen, Patrick Y;
Aldape, Kenneth J;
Lukas, Rimas V;
Galanis, Evanthia;
Eberhart, Charles G;
Brat, Daniel J;
Sarkaria, Jann N

Publication type:

Article

Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1540, doi. 10.1093/neuonc/noz116

By:

Pierce, Angela M;
Witt, Davis A;
Donson, Andrew M;
Gilani, Ahmed;
Sanford, Bridget;
Sill, Martin;
Court, Benjamin Van;
Oweida, Ayman;
Prince, Eric W;
Steiner, Jenna;
Danis, Etienne;
Dorris, Kathleen;
Hankinson, Todd;
Handler, Michael H;
Jones, Kenneth L;
Karam, Sana D;
Serkova, Natalie J;
Vibhakar, Rajeev;
Foreman, Nicholas K;
Griesinger, Andrea M

Publication type:

Article

Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma.

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1529, doi. 10.1093/neuonc/noz127

By:

Guo, Gao;
Gong, Ke;
Puliyappadamba, Vineshkumar Thidil;
Panchani, Nishah;
Pan, Edward;
Mukherjee, Bipasha;
Damanwalla, Ziba;
Bharia, Sabrina;
Hatanpaa, Kimmo J;
Gerber, David E;
Mickey, Bruce E;
Patel, Toral R;
Sarkaria, Jann N;
Zhao, Dawen;
Burma, Sandeep;
Habib, Amyn A

Publication type:

Article